#neogenomics

Analysts Predict Upside for NeoGenomics, Inc. (Nasdaq:NEO), Finishing At $13.84

NeoGenomics, Inc. (Nasdaq:NEO)

August 7th, 2018

NeoGenomics, Inc. fell $1.03 Sunday which equals a 6.93% drop, closing at $13.84. (more…)

Breaking 52 Week High, NeoGenomics, Inc. (Nasdaq:NEO) Settle At $14.25

NeoGenomics, Inc. (Nasdaq:NEO)

July 10th, 2018

With markets going up NeoGenomics, Inc. finished up $0.22 Sunday, up 1.57%, closing at $14.25. Furthermore it hit a new 52 week high of $14.35. The stock continues to trade well at 101% of its 52 week low of $7.08. It’s expected that NeoGenomics, Inc. will report earnings within the next couple of weeks. (more…)

(Nasdaq:NEO) NeoGenomics, Inc. Breaks 52 Week High Record Of $13.61

NeoGenomics, Inc. (Nasdaq:NEO)

June 21st, 2018

NeoGenomics, Inc. closed Wednesday up 0.60%, a $0.08 increase to close on $13.47. In addition it hit a new 52 week high of $13.61. While it is positive news the stock ended higher, the trading volumes were only 0.00% of normal which could be an indication of investor uncertainty.

NEO outperformed the rest of the Healthcare sector which went up…

(Nasdaq:NEO) NeoGenomics, Inc. Sets 52 Week High Record

NeoGenomics, Inc. (Nasdaq:NEO)

June 20th, 2018

Amidst falling markets NeoGenomics, Inc. rose $0.39 Tuesday, up 3.00%, closing at $13.39. In addition it hit a new 52 week high of $13.40. While it is positive news the stock ended higher, the trading volumes were only 0.00% of normal which could be an indication of investor uncertainty.

NEO outperformed the rest of the Healthcare sector which…

Hitting 52 Week High, NeoGenomics, Inc. (Nasdaq:NEO) Close At $12.96

NeoGenomics, Inc. (Nasdaq:NEO)

June 11th, 2018

With markets going up NeoGenomics, Inc. went up $0.20 Tuesday, a 1.57% increase, closing at $12.96. In addition it hit a new 52 week high of $12.99.

NEO outperformed the rest of the Healthcare sector which went up 0.10% today.

Analysis results from 6 analysts suggest that NeoGenomics, Inc. might decline somewhat (-4.62%), while Finboxhas…

Hitting 52 Week High, NeoGenomics, Inc. (Nasdaq:NEO) Ends The Day At $12.54

NeoGenomics, Inc. (Nasdaq:NEO)

June 1st, 2018

Amidst rising markets NeoGenomics, Inc. closed Saturday up 8.10%, a $0.94 increase to close on $12.54. In addition it hit a new 52 week high of $12.95. In addition to finishing higher, trading volumes were solid at 286% of normal which can indicate investors see opportunities.

NEO outperformed the rest of the Healthcare sector which went up…

NeoGenomics to Pay $275M for Clarient

More on this recent news to follow on thoughts about implications for pathology market as a whole and digital pathology (including GE-Omnyx).  GE paid $587 million for Clarient in an announcement 5 years ago today.

NeoGenomics, a biotech company specializing in genomic cancer diagnostics, has announced the acquisition of Clarient, a unit of General Electric (GE) Healthcare’s Life Sciences…